News

*SOLD OUT* FUNNY QUIZ x MS SOCIETY Fundraising Event

We’re thrilled to announce that the FUNNY QUIZ x MS Society SA & NT fundraising event is officially SOLD OUT!A heartfelt thank you to everyone who secured tickets, we can’t wait to share an unforgettable night of laughter and purpose with you all.Missed out? Don’t worry, you can still join the waitlist in case spots open up, by CLICKING […]

*SOLD OUT* FUNNY QUIZ x MS SOCIETY Fundraising Event Read More »

Double Your Impact: MS Mighty Swim Announces Dollar Match Day

The MS Society SA & NT has announced an exciting opportunity for supporters of our landmark 20th anniversary Mighty Swim event. This Saturday, February 1, every donation made will be doubled thanks to a generous anonymous donor who has pledged up to $10,000 in matching funds. Starting at 7am Saturday, all donations to the MS

Double Your Impact: MS Mighty Swim Announces Dollar Match Day Read More »

Promising Antiviral Drugs Identified for Multiple Sclerosis Treatment

Australian researchers have identified four existing antiviral medications that show promise in treating Multiple Sclerosis (MS), potentially opening a new frontier in MS treatment. These drugs, already approved for other conditions, could be “repurposed” to target the Epstein-Barr virus (EBV), which has been strongly linked to the development of MS. The selected medications – famciclovir,

Promising Antiviral Drugs Identified for Multiple Sclerosis Treatment Read More »

Join Our Team: Engagement & Partnerships Manager Role Now Open

The MS Society SA & NT is seeking a dynamic Engagement & Partnerships Manager to join our team at our new Wellness Centre in Kilkenny. This is pivotal role in our Fundraising and Marketing team that will drive community engagement and fundraising initiatives that directly support people living with MS across South Australia and the

Join Our Team: Engagement & Partnerships Manager Role Now Open Read More »

First NMOSD-Specific Treatment Recommended for PBS Listing

Exciting progress has been made for the NMOSD community with the Pharmaceutical Benefits Advisory Committee (PBAC) recommending ravulizumab (Ultomiris®) for PBS listing. This marks a historic milestone as the first treatment specifically for neuromyelitis optica spectrum disorders (NMOSD) to be recommended for inclusion on the Pharmaceutical Benefits Scheme. NMOSD is a group of autoimmune conditions

First NMOSD-Specific Treatment Recommended for PBS Listing Read More »

New CEO appointed to lead MS Society SA & NT

The Multiple Sclerosis Society of South Australia and Northern Territory has appointed experienced social sector leader Shaun Kennedy as its new Chief Executive Officer. Mr Kennedy, who commenced in the role on the 9th of December, brings extensive executive experience across private enterprise, government and not-for-profit sectors, with expertise in NDIS service delivery and social

New CEO appointed to lead MS Society SA & NT Read More »

MS Australia Launches National Research Platform to Investigate EBV Link with MS

MS Australia has taken a major step forward in multiple sclerosis research with the launch of a new national collaborative platform focused on understanding the relationship between Epstein-Barr virus (EBV) and MS. The EBV in MS National Collaborative Platform, unveiled at MS Australia’s inaugural Frontiers in MS Research Symposium at the University of Sydney on

MS Australia Launches National Research Platform to Investigate EBV Link with MS Read More »